Elizabeth Dougherty
is a science writer at the Novartis Institutes for BioMedical Research.
Tags Archive Navigation
icon
-
Visualizing immuno-oncology research
-
Tracking patients’ progress with radio signals and machine learning
-
Tackling the common denominator in liver disease
-
Stepping toward regenerative medicine for diabetes
-
Quest for a new measure of mental health
-
Researchers aim to beat trick play by tumors with drug combo
-
Reaping cancer clues from the blood
-
Organic dealmaker for drug discovery
-
Open science demystified
-
Novartis and Pfizer join forces to upend oncology dogma
-
New drug manufacturing tools change pharma chemistry
-
Not your grandparents’ nuclear medicine